Skip to main content
. Author manuscript; available in PMC: 2024 Jul 21.
Published in final edited form as: Lancet. 2022 Sep 5;400(10356):921–972. doi: 10.1016/S0140-6736(22)01273-9

Figure 15: Maps of the incidence of moderate or severe exacerbations (A) and pneumonia (B) in patients with chronic obstructive pulmonary disease.

Figure 15:

Data sourced from the IMPACT study.207 This figure is redrawn with permission from GlaxoSmithKline.